These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

180 related articles for article (PubMed ID: 33620125)

  • 1. The prognostic significance of race in nasopharyngeal carcinoma by histological subtype.
    Stepan KO; Mazul AL; Skillington SA; Paniello RC; Rich JT; Zevallos JP; Jackson RS; Pipkorn P; Massa S; Puram SV
    Head Neck; 2021 Jun; 43(6):1797-1811. PubMed ID: 33620125
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A Comprehensive Analysis of Treatment Management and Survival Outcomes in Nasopharyngeal Carcinoma.
    Goshtasbi K; Lehrich BM; Birkenbeuel JL; Abiri A; Harris JP; Kuan EC
    Otolaryngol Head Neck Surg; 2021 Jul; 165(1):93-103. PubMed ID: 33231508
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Lymph Node Status and Outcomes for Nasopharyngeal Carcinoma According to Histological Subtypes: A SEER Population-Based Retrospective Analysis.
    Guo R; Wu H; Wang J; Lian CL; He ZY; Zhang WW; Chen YX; Wu SG
    Adv Ther; 2019 Nov; 36(11):3123-3133. PubMed ID: 31559602
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Subtype Specific Nasopharyngeal Carcinoma Incidence and Survival Trends: Differences between Endemic and Non-Endemic Populations.
    Argirion I; Zarins KR; Suwanrungruang K; Pongnikorn D; Chitapanarux I; Sriplung H; Vatanasapt P; Rozek LS
    Asian Pac J Cancer Prev; 2020 Nov; 21(11):3291-3299. PubMed ID: 33247687
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Association Between Mortality Due to Nasopharyngeal Carcinoma and Race in the United States From 2007 to 2016.
    Raslan S; Rodriguez E; Zheng C; Lozano J; Barengo NC; Sargi Z
    Asian Pac J Cancer Prev; 2023 Mar; 24(3):915-921. PubMed ID: 36974545
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Histological subtype remains a prognostic factor for survival in nasopharyngeal carcinoma patients.
    Pan XX; Liu YJ; Yang W; Chen YF; Tang WB; Li CR
    Laryngoscope; 2020 Mar; 130(3):E83-E88. PubMed ID: 31188486
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A nation-wide epidemiological study on the risk of developing second malignancies in patients with different histological subtypes of nasopharyngeal carcinoma.
    Ooft ML; van Ipenburg J; Braunius WW; Stegeman I; Wegner I; de Bree R; Overbeek LI; Koljenović S; Willems SM
    Oral Oncol; 2016 May; 56():40-6. PubMed ID: 27086485
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prognostic factor analysis in patients with early-stage nasopharyngeal carcinoma in the USA.
    Liu P; Xue XM; Zhang C; Zhou HW; Ding ZW; Jiang YK; Wang L; Shen WD; Yang SM; Wang FY
    Future Oncol; 2023 May; 19(15):1063-1072. PubMed ID: 37283023
    [No Abstract]   [Full Text] [Related]  

  • 9. Survival effect of pretreatment FDG-PET-CT on nasopharyngeal cancer.
    Yang PC; Chen WM; Chen M; Shia BC; Wu SY; Chiang CW
    J Formos Med Assoc; 2023 Jan; 122(1):36-46. PubMed ID: 35999158
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A new prognostic histopathologic classification of nasopharyngeal carcinoma.
    Wang HY; Chang YL; To KF; Hwang JS; Mai HQ; Feng YF; Chang ET; Wang CP; Kam MK; Cheah SL; Lee M; Gao L; Zhang HZ; He JH; Jiang H; Ma PQ; Zhu XD; Zeng L; Chen CY; Chen G; Huang MY; Fu S; Shao Q; Han AJ; Li HG; Shao CK; Huang PY; Qian CN; Lu TX; Li JT; Ye W; Ernberg I; Ng HK; Wee JT; Zeng YX; Adami HO; Chan AT; Shao JY
    Chin J Cancer; 2016 May; 35():41. PubMed ID: 27146632
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Construction of a comprehensive nutritional index and comparison of its prognostic performance with the PNI and NRI for survival in older patients with nasopharyngeal carcinoma: a retrospective study.
    Duan YY; Deng J; Su DF; Li WQ; Han Y; Li ZX; Huan XZ; Zhu SH; Yang QL; Hu W; Xin MZ; Tang LQ; Mai HQ; Fan YY; He Y
    Support Care Cancer; 2021 Sep; 29(9):5371-5381. PubMed ID: 33686519
    [TBL] [Abstract][Full Text] [Related]  

  • 12. CD3+T-lymphocyte infiltration is an independent prognostic factor for advanced nasopharyngeal carcinoma.
    Al-Rajhi N; Soudy H; Ahmed SA; Elhassan T; Mohammed SF; Khoja HA; Ghebeh H
    BMC Cancer; 2020 Mar; 20(1):240. PubMed ID: 32199452
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of prior cancer on trial eligibility and treatment outcomes in nasopharyngeal carcinoma: Implications for clinical trial accrual.
    Wang YQ; Lv JW; Tang LL; Du XJ; Chen L; Li WF; Liu X; Guo Y; Lin AH; Mao YP; Sun Y; Chen YP; Ma J
    Oral Oncol; 2019 Mar; 90():23-29. PubMed ID: 30846172
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Development and validation of prognostic nomograms in patients with ascending type of nasopharyngeal carcinoma: Retrospective study based on SEER database.
    Chen KH; Jiang YT; Zhao R; Sun YC; Zhu XD
    Head Neck; 2022 Dec; 44(12):2649-2659. PubMed ID: 36054033
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prognostic factors of nasopharyngeal carcinoma patients in a tertiary referral hospital: a retrospective cohort study.
    Siti-Azrin AH; Norsa'adah B; Naing NN
    BMC Res Notes; 2017 Dec; 10(1):705. PubMed ID: 29212521
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prognostic value of prognostic nutritional index in nasopharyngeal carcinoma: A meta-analysis containing 4511 patients.
    Tu X; Ren J; Zhao Y
    Oral Oncol; 2020 Nov; 110():104991. PubMed ID: 32919361
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Factors Associated With Mortality in Pediatric vs Adult Nasopharyngeal Carcinoma.
    Richards MK; Dahl JP; Gow K; Goldin AB; Doski J; Goldfarb M; Nuchtern J; Langer M; Beierle EA; Vasudevan S; Hawkins DS; Parikh SR
    JAMA Otolaryngol Head Neck Surg; 2016 Mar; 142(3):217-22. PubMed ID: 26769566
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pre-treatment amide proton transfer imaging predicts treatment outcome in nasopharyngeal carcinoma.
    Qamar S; King AD; Ai QH; Mo FKF; Chen W; Poon DMC; Tong M; Ma BB; Yeung DK; Wang YX; Yuan J
    Eur Radiol; 2020 Nov; 30(11):6339-6347. PubMed ID: 32588210
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The diagnostic and prognostic values of plasma Epstein-Barr virus DNA for residual cervical lymphadenopathy in nasopharyngeal carcinoma patients: a retrospective study.
    Liu SL; Sun XS; Li XY; Tang LQ; Chen QY; Lin HX; Liang YJ; Yan JJ; Lin C; Guo SS; Liu LT; Li Y; Xie HJ; Tang QN; Liang H; Guo L; Mai HQ
    Cancer Commun (Lond); 2019 Mar; 39(1):14. PubMed ID: 30925939
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Association between time from diagnosis to treatment and survival of patients with nasopharyngeal carcinoma: A population-based cohort study.
    Wei X; Yu S; Wang J; Xiang Z; Liu L; Min Y
    Curr Probl Cancer; 2024 Feb; 48():101060. PubMed ID: 38211418
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.